Impact of GEA Simultaneous to VSG on Post-operative GERD

The goal of this clinical trial is to evaluate the effect of GEA on GERD in patients undergoing VSG. The main question it aims to answer is: • Does adoption of GEA to VSG reduce the occurrence of GERD? Participants will complete a symptom questionnaire during follow-up visits. All exams are already part of the surgical or GERD follow-up routine. Researchers will compare with GEA (Group A) and Without GEA (Group B) to see if adopting GEA during VSG reduces the occurrence of GERD.

NCT Number	NCT07537244
Lead Sponsor	Clinica Gastrobese
Conditions	Obesity, Reflux, Gastroesophageal
Enrollment	60 participants
Start Date	2023-02-18
Primary Completion	2024-03-04 (estimated)
Study Completion	2028-04 (estimated)
Updated on ClinicalTrials.gov	2026-04-17